The suggested mechanism for BTK to increase the risk of pericardial effusions is inhibition of platelet-derived growth factor receptor β (PDGFR-β) and Src family tyrosine kinases, which regulate endothelial permeability and interstitial tissue pressure [14]. The gene discussed is PDGFRB; the disease is pericardial effusion.